DGAP-News: Axon Neuroscience to Present at 2021 BIO Digital

NEW YORK, NY / ACCESSWIRE / June 10, 2021 / AXON NEUROSCIENCE SE & AXON COVIDAX a. s. (together "Axon"), clinical stage biotech company in the field of Alzheimer's disease with first-in-man tau vaccine AADvac1 announced today that it will deliver a company presentation at the biotech event BIO Digital scheduled June 10-11 & 14-18, 2021.